Literature DB >> 26614271

Fibroblast growth factor 23 and heart failure: the plot thickens.

Orlando M Gutiérrez1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26614271      PMCID： PMC4902866          DOI： 10.1093/ndt/gfv401

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN： 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  28 in total

1.  FGF23 protein expression in coronary arteries is associated with impaired kidney function.

Authors:  Natalie A van Venrooij; Renata C Pereira; Yin Tintut; Michael C Fishbein; Navdeep Tumber; Linda L Demer; Isidro B Salusky; Katherine Wesseling-Perry
Journal:  Nephrol Dial Transplant       Date:  2014-01-23       Impact factor: 5.992

2.  Inorganic phosphate and FGF-23 predict outcome in stable systolic heart failure.

Authors:  Max Plischke; Stephanie Neuhold; Christopher Adlbrecht; Bernhard Bielesz; Sascha Shayganfar; Christian Bieglmayer; Thomas Szekeres; Walter H Hörl; Guido Strunk; Patrick Vavken; Richard Pacher; Martin Hülsmann
Journal:  Eur J Clin Invest       Date:  2011-12-13       Impact factor: 4.686

3.  Associations between fibroblast growth factor 23 and cardiac characteristics in pediatric heart failure.

Authors:  Tamara Isakova; Jessica Houston; Laura Santacruz; Eva Schiavenato; Gabriel Somarriba; William G Harmon; Steven E Lipshultz; Tracie L Miller; Paolo G Rusconi
Journal:  Pediatr Nephrol       Date:  2013-06-06       Impact factor: 3.714

4.  FGF23 is a novel regulator of intracellular calcium and cardiac contractility in addition to cardiac hypertrophy.

Authors:  Chad D Touchberry; Troy M Green; Vladimir Tchikrizov; Jaimee E Mannix; Tiffany F Mao; Brandon W Carney; Magdy Girgis; Robert J Vincent; Lori A Wetmore; Buddhadeb Dawn; Lynda F Bonewald; Jason R Stubbs; Michael J Wacker
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-02-26       Impact factor: 4.310

5.  Pathophysiological impact of serum fibroblast growth factor 23 in patients with nonischemic cardiac disease and early chronic kidney disease.

Authors:  Miki Imazu; Hiroyuki Takahama; Hiroshi Asanuma; Akira Funada; Yasuo Sugano; Takahiro Ohara; Takuya Hasegawa; Masanori Asakura; Hideaki Kanzaki; Toshihisa Anzai; Masafumi Kitakaze
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-09-12       Impact factor: 4.733

6.  FGF-23 dysregulates calcium homeostasis and electrophysiological properties in HL-1 atrial cells.

Authors:  Yu-Hsun Kao; Yao-Chang Chen; Yung-Kuo Lin; Rong-Jie Shiu; Tze-Fan Chao; Shih-Ann Chen; Yi-Jen Chen
Journal:  Eur J Clin Invest       Date:  2014-08       Impact factor: 4.686

7.  Association of Fibroblast Growth Factor-23 Levels and Angiotensin-Converting Enzyme Inhibition in Chronic Systolic Heart Failure.

Authors:  Peter Wohlfahrt; Vojtech Melenovsky; Martin Kotrc; Jan Benes; Antonin Jabor; Janka Franekova; Sophia Lemaire; Josef Kautzner; Petr Jarolim
Journal:  JACC Heart Fail       Date:  2015-10       Impact factor: 12.035

8.  Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease.

Authors:  Orlando M Gutiérrez; James L Januzzi; Tamara Isakova; Karen Laliberte; Kelsey Smith; Gina Collerone; Ammar Sarwar; Udo Hoffmann; Erin Coglianese; Robert Christenson; Thomas J Wang; Christopher deFilippi; Myles Wolf
Journal:  Circulation       Date:  2009-05-04       Impact factor: 29.690

9.  Fibroblast growth factor-23 and cardiovascular disease in the general population: the Multi-Ethnic Study of Atherosclerosis.

Authors:  Bryan Kestenbaum; Michael C Sachs; Andy N Hoofnagle; David S Siscovick; Joachim H Ix; Cassianne Robinson-Cohen; Joao A C Lima; Joseph F Polak; Marc Blondon; John Ruzinski; Denise Rock; Ian H de Boer
Journal:  Circ Heart Fail       Date:  2014-03-25       Impact factor: 8.790

10.  Serum intact FGF23 associate with left ventricular mass, hypertrophy and geometry in an elderly population.

Authors:  Majd A I Mirza; Anders Larsson; Håkan Melhus; Lars Lind; Tobias E Larsson
Journal:  Atherosclerosis       Date:  2009-05-21       Impact factor: 5.162
View more
  1 in total

1.  FGF23 modulates the effects of erythropoietin on gene expression in renal epithelial cells.

Authors:  Mitsuru Yashiro; Masaki Ohya; Toru Mima; Yumi Ueda; Yuri Nakashima; Kazuki Kawakami; Yohei Ishizawa; Shuto Yamamoto; Sou Kobayashi; Takurou Yano; Yusuke Tanaka; Kouji Okuda; Tomohiro Sonou; Tomohiro Shoshihara; Yuko Iwashita; Yu Iwashita; Kouichi Tatsuta; Ryo Matoba; Shigeo Negi; Takashi Shigematsu
Journal:  Int J Nephrol Renovasc Dis       Date:  2018-04-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.